Prevalence and characterization of NS5A resistance associated variants (RAVs) in patients who relapsed following exposure to NS5A inhibitors

by Guillaume Penaranda, Philippe Halfon, Caroline Scholtès, Sofiane Mohamed, Vincent Leroy, Marc Bourlière, Denis Ouzan, Guillaume Pénaranda, Hacène Khiri, Laura Polverel, Fabien Zoulim, Marie-Ange Thélu, Sylvie Larrat
Published 2016-05-01